Pengzhou Kong

机构：Shanxi Medical University, Shanxi University · ORCID：0000-0001-8351-9235

发表论文 70 篇 · 总被引 2005 次 · h-index 21

代表论文

• Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma (2022 · Cancer Cell · 被引 186)
• Cyclovirobuxine D inhibits growth and progression of non‑small cell lung cancer cells by suppressing the KIF11‑CDC25C‑CDK1‑CyclinB1 G 2 /M phase transition regulatory network and the NFκB/JNK signaling pathway (2023 · International Journal of Oncology · 被引 22)
• Palbociclib Enhances Migration and Invasion of Cancer Cells via Senescence-Associated Secretory Phenotype-Related CCL5 in Non-Small-Cell Lung Cancer (2022 · Journal of Oncology · 被引 16)
• Multi-omics analysis reveals immunosuppression in oesophageal squamous cell carcinoma induced by creatine accumulation and HK3 deficiency (2025 · Genome Medicine · 被引 9)
• KLF7 Promotes Hepatocellular Carcinoma Progression Through Regulating SLC1A5 ‐Mediated Tryptophan Metabolism (2024 · Journal of Cellular and Molecular Medicine · 被引 7)
• YEATS2 promotes malignant phenotypes of esophageal squamous cell carcinoma via H3K27ac activated-IL6ST (2025 · Frontiers in Cell and Developmental Biology · 被引 5)